GLP-1 Weight Loss Drugs May Slow Spread Of Several Cancers
A new real-world study from the Cleveland Clinic suggests popular GLP-1 weight-loss medications might slow how some obesity-related cancers spread, with notable reductions in progression for lung, breast, colorectal and liver cancers; researchers warn the analysis is retrospective and more trials are needed to confirm whether the drugs are doing the protecting or if other...